Leonardo Roever: The Emerging Role of the TyHGB Index in Predicting New-Onset Stroke
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by AoMen Lu and Qian Xu , published in Lipids in Health and Disease, adding:
”Association between the triglyceride-HDL-glucose-body index and the risk of recent-onset stroke: a prospective cohort study
Stroke is a leading cause of mortality and disability in China.
Insulin resistance (IR) is a crucial modifiable risk factor.
Although the triglyceride-glucose (TyG) index is a recognized surrogate marker for IR, it ignores the protective role of HDL cholesterol (HDL-C) and the impact of obesity (BMI).
The new TyHGB index integrates triglycerides, fasting glucose, HDL-C, and BMI, offering a comprehensive metabolic profile.
Long-term elevated patterns and the cumulative burden of the TyHGB index are independent risk factors for recent-onset stroke.
The identification of an inflection point derived from the RCS (25,76) serves as a useful population-level reference value.
The TyHGB index provides incremental value compared to the isolated TyG index in risk stratification, highlighting the importance of dynamic metabolic monitoring for stroke prevention.”
Title: Association between the triglyceride-high-density lipoprotein-glucose-body index and new-onset stroke risk: a prospective cohort study
Authors: AoMen Lu and Qian Xu
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian